Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05241418 · ClinicalTrials.gov registry record
Atrial Late Gadolinium Enhancement in Patients with Repaired Congenital Heart Disease
A clinical trial of Congenital Heart Disease and Fibrosis Myocardial, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT05241418 is a study of Congenital Heart Disease and Fibrosis Myocardial that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 50 participants, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05241418, a study of Congenital Heart Disease and Fibrosis Myocardial, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
In this research study the investigators want to learn more about how well the investigators can visualize scar tissue in the heart by MRI. In patients with congenital heart disease who need a procedure in the electrophysiology laboratory, how the MRI findings match the findings in the electrophysiology laboratory is not known. This study works to answer these questions. Participants will undergo a cardiac MRI as part of the routine clinical care that was ordered by their doctors and additional imaging by cardiac MRI will be performed.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Atrial 3D late gadolinium enhancement
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-03-23 |
| Est. Completion | 2029-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05241418
The ClinicalTrials.gov registry entry for NCT05241418 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (89% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Atrial 3D late gadolinium enhancement is the first listed.
NCT05241418 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05241418 about?
NCT05241418 is a clinical study titled "Atrial Late Gadolinium Enhancement in Patients with Repaired Congenital Heart Disease". In this research study the investigators want to learn more about how well the investigators can visualize scar tissue in the heart by MRI. In patients with congenital heart disease who need a procedure in the electrophysiology laboratory, how the MRI findings match the findings in the electrophysio...
What is the current status of trial NCT05241418?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2022-03-23. Estimated completion is 2029-06-30.
What conditions does trial NCT05241418 study?
This clinical trial studies the following conditions: Congenital Heart Disease, Fibrosis Myocardial, Fibrosis; Heart.
What interventions are being tested in trial NCT05241418?
The interventions under investigation include: Atrial 3D late gadolinium enhancement (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05241418?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05241418 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fontan Fitness Trial
RECRUITING · NA
-
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
RECRUITING
-
A Study of Invasive Hemodynamic for MACHD Registry
RECRUITING
-
Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables
RECRUITING
-
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
RECRUITING
-
PDA for Kidneys Study
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.